has been involved in all aspects ofketamineresearch from rodent models to clinical implementation. We spoke with Sanacora about the complexities of ketamine treatment and the risks of at-home use.
The choice of therapy demands careful consideration of the balance between risks and benefits, as many options have not been studied well in this population. Painful and stressful procedures in neonates … All newborns, particularly those in need of intensive care, experience various painful stimuli ...
"There is not a lot of peer-reviewed research or safety data available for microdosing psychedelics, because these substances are not as well-studied as more traditional interventions," Dr. Adam D. Scioli, chief medical officer of Caron Treatment Centers in Pennsylvania, told Fox News Digital. ...
or a combination of the two. Cognitive behavioral therapy (CBT), for instance, has proven to be highly effective against depression. The first goal of CBT is to enable the patient to identify and reduce frequent, intense negative thoughts —“This is too hard to do,” for example. ...
“safe and effective” are generally limited to a few dozen patients and a year or two of follow up. Areview article in the Lancetpublished in April 2016toutedas providing “an evidence-based overview of the benefits, risks, and effects of testosterone therapy in transgender men” observed ...
Propofol, whichis given for anesthesia but is also a sedative. It brings on the deep-sleep state and also keeps you there. You will likely get other IV drugs along with etomidate, ketamine, or propofol so they work better or longer. Some of the most common medications are opioids, lidocai...
Phosphorus 31 magnetic resonance spectroscopy (P-31 MRS) was used to study noninvasively the intracellular free Mg2+ concentration and cellular bioenergetic state of rat brain in vivo before and after fluid percussion-induced traumatic brain injury of graded severity. Brain injury was induced at four...
This study aimed to evaluate the clinical benefits and assess the potential risks for adverse events or side effects of NMDAR antagonists that were investigated for the treatment of severe opioid use disorder.Fluyau, DimyRevadigar, NeelambikaPierre, Christopher G....